Abstract
Uveal melanoma is the most common primary intraocular tumor in adults and exclusively disseminates haematogenously in order to form metastases. The aim of this study was to measure the transcriptional profiles of human uveal melanoma cells isolated from a primary intraocular tumor, circulating malignant cells (CMCs), and metastases in order to elucidate the changes in gene expression associated with this progression. Human EST microarrays and universal reference RNA were used to measure the differences between tissue samples isolated from an immunosuppressed xenograft rabbit model of uveal melanoma. Cells were isolated from a single rabbit at the time of sacrifice from an intraocular tumor, peripheral blood, and metastasis. RNA was extracted from each sample and subjected to transcriptional profiling analysis. Results were compared to the transcriptional profiles previously obtained from the original cell line used for intraocular injections. Changes were verified using real-time PCR analysis. A total of 314 significant changes in gene expression were seen from the intraocular tumor to metastasis, as determined by transcript abundance. Principle Components Analysis was used to cluster these changes into four distinct groups. An additional 61 statistically significant changes were observed between the recultured and CMCs, with the latter believed to represent an intermediate step in the progression from intraocular tumor to metastasis. In conclusion, we have produced a detailed analysis of the transcriptional changes that take place as human uveal melanoma cells evolve from a primary tumor to metastasis in a xenograft animal model, including the decrease in expression of specific melanoma markers.
Similar content being viewed by others
References
Char DH (2001) Tumors of the eye and ocular adnexa. Atlas of clinical oncology, Hamilton Lewiston, B.C. Decker, NY; Sales and distribution, US., B.C. Decker. xiv, p 476
Diener-West M, Earle JD, Fine SL, Hawkins BS, Moy CS, Reynolds SM et al (2001) The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma, III: initial mortality findings. COMS Report No. 18. Arch Ophthalmol 119(7):969–982
Singh AD, Topham A (2003) Survival rates with uveal melanoma in the United States: 1973–1997. Ophthalmology 110(5):962–965
Kilic E, van Gils W, Lodder E, Beverloo HB, van Til ME, Mooy CM et al (2006) Clinical and cytogenetic analyses in uveal melanoma. Invest Ophthalmol Vis Sci 47(9):3703–3707
Pantel K, Brakenhoff RH (2004) Dissecting the metastatic cascade. Nat Rev Cancer 4(6):448–456
Lopez-Velasco R, Morilla-Grasa A, Saornil-Alvarez MA, Ordonez JL, Blanco G, Rabano G et al (2005) Efficacy of five human melanocytic cell lines in experimental rabbit choroidal melanoma. Melanoma Res 15(1):29–37
Blanco G, Saornil AM, Domingo E, Diebold Y, Lopez R, Rabano G et al (2000) Uveal melanoma model with metastasis in rabbits: effects of different doses of cyclosporine A. Curr Eye Res 21(3):740–747
Blanco PL, Marshall JC, Antecka E, Callejo SA, Souza Filho JP, Saraiva V et al (2005) Characterization of ocular and metastatic uveal melanoma in an animal model. Invest Ophthalmol Vis Sci 46(12):4376–4382
Blanco PL, Caissie AL, Burnier MN Jr (2004) Experimental models of uveal melanoma. Can J Ophthalmol 39(4):441–447
Onken MD, Worley LA, Ehlers JP, Harbour JW (2004) Gene expression profiling in uveal melanoma reveals two molecular classes and predicts metastatic death. Cancer Res 64(20):7205–7209
Onken MD, Ehlers JP, Worley LA, Makita J, Yokota Y, Harbour JW (2006). Functional gene expression analysis uncovers phenotypic switch in aggressive uveal melanomas. Cancer Res 66(9):4602–4609
Diebold Y, Blanco G, Saornil MA, Fernandez N, Lazaro MC (1997) Morphologic and immunocytochemical characterization of four human uveal cell lines (melanoma- and melanocytes-derived). Curr Eye Res 16(5):487–495
De Waard-Siebinga I, Blom DJ, Griffioen M, Schrier PI, Hoogendoorn E, Beverstock G et al (1995) Establishment and characterization of an uveal-melanoma cell line. Int J Cancer 62(2):155–161
Marshall JC, Caissie AL, Callejo SA, Antecka E, Burnier MN Jr (2004) Cell proliferation profile of five human uveal melanoma cell lines of different metastatic potential. Pathobiology 71(5):241–245
Marshall JC, Gordon KD, McCauley CS, de Souza Filho JP, Burnier MN (2006) The effect of blue light exposure and use of intraocular lenses on human uveal melanoma cell lines. Melanoma Res 16(6):537–541
Callejo SA, Antecka E, Blanco PL, Edelstein C, Burnier MN (2006) Identification of circulating malignant cells and its correlation with prognostic factors and treatment in uveal melanoma. A prospective longitudinal study. Eye (in press)
Hendrix MJ, Seftor EA, Seftor RE, Gardner LM, Boldt HC, Meyer M et al (1998) Biologic determinants of uveal melanoma metastatic phenotype: role of intermediate filaments as predictive markers. Lab Invest 78(2):153–163
Thomas PA, Kirschmann DA, Cerhan JR, Folberg R, Seftor EA, Sellers TA et al (1999) Association between keratin and vimentin expression, malignant phenotype, and survival in postmenopausal breast cancer patients. Clin Cancer Res 5(10):2698–2703
Kaplan RN, Riba RD, Zacharoulis S, Bramley AH, Vincent L, Costa C et al (2005) VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 438(7069):820–827
Berube M, Talbot M, Collin C, Paquet-Bouchard C, Germain L, Guerin SL et al (2005) Role of the extracellular matrix proteins in the resistance of SP6.5 uveal melanoma cells toward cisplatin. Int J Oncol 26(2):405–413
Economou MA, All-Ericsson C, Bykov V, Girnita L, Bartolazzi A, Larsson O et al (2005) Receptors for the liver synthesized growth factors IGF-1 and HGF/SF in uveal melanoma: intercorrelation and prognostic implications. Invest Ophthalmol Vis Sci 46(12):4372–4375
Girnita A, All-Ericsson C, Economou MA, Astrom K, Axelson M, Seregard S et al (2006) The insulin-like growth factor-I receptor inhibitor picropodophyllin causes tumor regression and attenuates mechanisms involved in invasion of uveal melanoma cells. Clin Cancer Res 12(4):1383–1391
Saltiel AR, Kahn CR (2001) Insulin signalling and the regulation of glucose and lipid metabolism. Nature 414(6865):799–806
Boissan M, Beurel E, Wendum D, Rey C, Lecluse Y, Housset C et al (2005) Overexpression of insulin receptor substrate-2 in human and murine hepatocellular carcinoma. Am J Pathol 167(3):869–877
Saraiva VS, Caissie AL, Segal L, Edelstein C, Burnier MN Jr (2005) Immunohistochemical expression of phospho-Akt in uveal melanoma. Melanoma Res 15(4):245–250
Ryazanov AG, Pavur KS, Dorovkov MV (1999) Alpha-kinases: a new class of protein kinases with a novel catalytic domain. Curr Biol 9(2):R43–R45
Versele M, Thorner J (2005) Some assembly required: yeast septins provide the instruction manual. Trends Cell Biol 15(8):414–424
Spiliotis ET, Kinoshita M, Nelson WJ (2005) A mitotic septin scaffold required for Mammalian chromosome congression and segregation. Science 307(5716):1781–1785
Torigoe T, Izumi H, Ishiguchi H, Yoshida Y, Tanabe M, Yoshida T et al (2005) Cisplatin resistance and transcription factors. Curr Med Chem Anticancer Agents 5(1):15–27
Jean S, Bideau C, Bellon L, Halimi G, De Meo M, Orsiere T et al (2001) The expression of genes induced in melanocytes by exposure to 365-nm UVA: study by cDNA arrays and real-time quantitative RT-PCR. Biochim Biophys Acta 1522(2):89–96
Hoashi T, Watabe H, Muller J, Yamaguchi Y, Vieira WD, Hearing VJ (2005) MART-1 is required for the function of the melanosomal matrix protein PMEL17/GP100 and the maturation of melanosomes. J Biol Chem 280(14):14006–14016
Vaisanen A, Kallioinen M, von Dickhoff K, Laatikainen L, Hoyhtya M, Turpeenniemi-Hujanen T (1999) Matrix metalloproteinase-2 (MMP-2) immunoreactive protein—a new prognostic marker in uveal melanoma? J Pathol 188(1):56–62
Rietschel P, Panageas KS, Hanlon C, Patel A, Abramson DH, Chapman PB (2005) Variates of survival in metastatic uveal melanoma. J Clin Oncol 23(31):8076–8080
Acknowledgment
Research is supported by a grant from the Cedars Cancer Institute of Canada.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Marshall, JC., Nantel, A., Blanco, P. et al. Transcriptional profiling of human uveal melanoma from cell lines to intraocular tumors to metastasis. Clin Exp Metastasis 24, 353–362 (2007). https://doi.org/10.1007/s10585-007-9072-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10585-007-9072-z